JP2021512127A5 - - Google Patents

Info

Publication number
JP2021512127A5
JP2021512127A5 JP2020541983A JP2020541983A JP2021512127A5 JP 2021512127 A5 JP2021512127 A5 JP 2021512127A5 JP 2020541983 A JP2020541983 A JP 2020541983A JP 2020541983 A JP2020541983 A JP 2020541983A JP 2021512127 A5 JP2021512127 A5 JP 2021512127A5
Authority
JP
Japan
Prior art keywords
formula
compound
alkyl
group
haloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020541983A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021512127A (ja
JP7402804B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IN2019/050076 external-priority patent/WO2019150392A1/en
Publication of JP2021512127A publication Critical patent/JP2021512127A/ja
Publication of JP2021512127A5 publication Critical patent/JP2021512127A5/ja
Application granted granted Critical
Publication of JP7402804B2 publication Critical patent/JP7402804B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020541983A 2018-02-01 2019-02-01 ピラゾール化合物及びその調製 Active JP7402804B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
IN201811003855 2018-02-01
IN201811003859 2018-02-01
IN201811003859 2018-02-01
IN201811003855 2018-02-01
IN201711042921 2018-05-30
IN201711042921 2018-05-30
PCT/IN2019/050076 WO2019150392A1 (en) 2018-02-01 2019-02-01 Pyrazole compounds and preparation thereof

Publications (3)

Publication Number Publication Date
JP2021512127A JP2021512127A (ja) 2021-05-13
JP2021512127A5 true JP2021512127A5 (cg-RX-API-DMAC7.html) 2022-01-27
JP7402804B2 JP7402804B2 (ja) 2023-12-21

Family

ID=67478207

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020541983A Active JP7402804B2 (ja) 2018-02-01 2019-02-01 ピラゾール化合物及びその調製

Country Status (14)

Country Link
US (1) US11873289B2 (cg-RX-API-DMAC7.html)
EP (1) EP3746434A4 (cg-RX-API-DMAC7.html)
JP (1) JP7402804B2 (cg-RX-API-DMAC7.html)
KR (1) KR102951622B1 (cg-RX-API-DMAC7.html)
CN (1) CN111670184B (cg-RX-API-DMAC7.html)
AU (1) AU2019213854C1 (cg-RX-API-DMAC7.html)
BR (1) BR112020015692A2 (cg-RX-API-DMAC7.html)
CA (1) CA3090204A1 (cg-RX-API-DMAC7.html)
IL (1) IL276410B2 (cg-RX-API-DMAC7.html)
MA (1) MA54677A (cg-RX-API-DMAC7.html)
MX (2) MX2020008151A (cg-RX-API-DMAC7.html)
MY (1) MY209060A (cg-RX-API-DMAC7.html)
SG (1) SG11202007328UA (cg-RX-API-DMAC7.html)
WO (1) WO2019150392A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA54677A (fr) 2018-02-01 2021-11-17 Myokardia Inc Composés pyrazoles et leur préparation
WO2025244956A1 (en) * 2024-05-20 2025-11-27 MyoKardia, Inc. Methods of manufacturing danicamtiv

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007284386A (ja) 2006-04-18 2007-11-01 Kumiai Chem Ind Co Ltd 3−ピラゾリルフェニルスルフィド誘導体及びそれを有効成分として含有する殺虫・殺ダニ・殺線虫剤
US8324178B2 (en) 2008-10-31 2012-12-04 The Regents Of The University Of California Method of treatment using alpha-1-adrenergic agonist compounds
US9260416B2 (en) 2011-05-27 2016-02-16 Amira Pharmaceuticals, Inc. Heterocyclic autotaxin inhibitors and uses thereof
CN104703972B (zh) 2012-08-30 2017-05-31 拜耳农作物科学股份公司 3,5‑双(卤烷基)‑吡唑‑4‑甲酸衍生物的脱羧方法
WO2014089913A1 (zh) 2012-12-12 2014-06-19 山东亨利医药科技有限责任公司 作为酪氨酸激酶抑制剂的并环化合物
EP3063134B1 (en) 2013-11-01 2020-08-12 Srf Limited Process for the preparation of pyrazole derivatives
EP3015458A1 (en) 2014-11-03 2016-05-04 Bayer CropScience AG Process for preparing 3,5-bis(haloalkyl)pyrazole derivatives from a,a-dihaloamines and ketimines
SG11201705928XA (en) 2015-01-22 2017-08-30 Myokardia Inc 4-methylsulfonyl-substituted piperidine urea compounds for the treatment of dilated cardiomyopathy (dcm)
US11452717B2 (en) 2017-01-10 2022-09-27 Sanford Burnham Prebys Medical Discovery Institute Small molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and uses thereof
CN111132964A (zh) 2017-04-11 2020-05-08 欧瑞克制药公司 糖皮质激素受体调节剂
MA54677A (fr) 2018-02-01 2021-11-17 Myokardia Inc Composés pyrazoles et leur préparation

Similar Documents

Publication Publication Date Title
JP2019516692A5 (cg-RX-API-DMAC7.html)
JP2014519486A (ja) トリフルオロメタンを用いる直接トリフルオロメチル化
JP2017505801A5 (cg-RX-API-DMAC7.html)
JP2020169140A (ja) パーフルオロアルキン化合物の製造方法
Xu et al. Incorporation of CO2 into organosilicon compounds via CSi bond cleavage
JP2014139151A (ja) (e)−1−ハロ−エナミド誘導体又はその塩を製造する方法及び(e)−1−ハロ−エナミド誘導体又はその塩。
IL276410B1 (en) Pyrazole compounds and preparation thereof
JP6388065B2 (ja) ジフルオロエステル化合物の製造方法
JP5234109B2 (ja) フルオロプロピレンカーボネートの製造法
WO2006046417A1 (ja) 3,3,3-トリフルオロプロピオン酸の製造方法
JP2022527050A (ja) フッ素化アルコールを調製する方法
TW201326116A (zh) 2,6-二乙基-4-甲基苯醋酸之製造方法
JP2015533373A5 (cg-RX-API-DMAC7.html)
JP6540690B2 (ja) ニトロ化合物の製造方法
JPH1192453A (ja) ピリジルメチルイソチオシアネートの製造法
JP5950255B2 (ja) 1,2−ビス(トリメチルシリル)ベンゼンまたはその類縁化合物の製造方法
EP3670484B1 (en) Processes for preparing 4-methyl-5-nonanone and 4-methyl-5-nonanol
JP4348063B2 (ja) 五員環シララクトン化合物の製造方法
JP2010528099A (ja) ホスフィンオキシドビタミンd前駆物質の製造方法
JP4386881B2 (ja) 3,3,3−トリフルオロプロピオン酸の製造方法
JP2003206254A (ja) 7−テトラデセン−2−オンの製造方法
EA044890B1 (ru) Пиразольные соединения и их получение
HK40027579A (en) Pyrazole compounds and preparation thereof
Wang Stereoselective synthesis of vinyl germanes and silanes. Applications of tris (trimethyl) germanes and silanes in palladium-catalyzed cross-coupling reactions
JP2008024613A (ja) 第1級アルコールの製造方法